Literature DB >> 19130889

Cloning, expression, isotope labeling, purification, and characterization of bovine antimicrobial peptide, lactophoricin in Escherichia coli.

Tae-Joon Park1, Ji-Sun Kim, Sung-Sub Choi, Yongae Kim.   

Abstract

Lactophoricin (LPcin-I) is a 23-amino acid peptide that corresponds to the carboxyterminal 113-135 region of component-3 of proteose peptone (PP3), a minor phosphoglycoprotein found in bovine milk. It has been reported that lactophoricin has antibacterial activity and a cationic amphipathic helical structure, but its shorter analogous peptide (LPcin-II), a 17-amino acid peptide, corresponding to the 119-135 region of PP3 does not display antibacterial activity. LPcin-I and LPcin-II have similar charge ratios and identical hydrophobic/hydrophilic sectors, according to their helical wheel projection patterns, and both peptides show cationic amphipathic helical folding and interact with membranes. However, it is known that only LPcin-I incorporates into planar lipidic bilayers to form voltage-dependent channels. In this study, the authors cloned and expressed the two recombinant peptides as ketosteroid isomerase (KSI) fusion proteins inclusion bodies in Escherichia coli. These peptides were subjected to NMR structural studies to explore their structure-activity relationships. Fusion proteins were purified by Ni-NTA affinity chromatography under denaturing conditions, and recombinant LPcin-I and LPcin-II were released from fusion by CNBr cleavage. Final purifications of LPcin-I and LPcin-II were achieved by preparative reversed-phase high performance liquid chromatography. Using these methods, we obtained several tens of milligrams of uniformly and selectively (15)N labeled peptides per liter of growth, which was sufficient for solid-state NMR spectroscopy. Peptides were identified by tris-tricine polyacrylamide gel electrophoresis and HSQC spectra. Initial structural data were obtained by solution NMR spectroscopy and compared in membrane-like environments.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19130889     DOI: 10.1016/j.pep.2008.12.009

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  12 in total

1.  Solution and solid-state NMR structural studies of antimicrobial peptides LPcin-I and LPcin-II.

Authors:  Tae-Joon Park; Ji-Sun Kim; Hee-Chul Ahn; Yongae Kim
Journal:  Biophys J       Date:  2011-09-07       Impact factor: 4.033

2.  NMR Structural Studies of Antimicrobial Peptides: LPcin Analogs.

Authors:  Ji-Ho Jeong; Ji-Sun Kim; Sung-Sub Choi; Yongae Kim
Journal:  Biophys J       Date:  2016-01-19       Impact factor: 4.033

3.  Design and high-level expression of a hybrid antimicrobial peptide LF15-CA8 in Escherichia coli.

Authors:  Xing-Jun Feng; Li-Wei Xing; Di Liu; Xue-Ying Song; Chun-Long Liu; Jing Li; Wen-Shan Xu; Zhong-Qiu Li
Journal:  J Ind Microbiol Biotechnol       Date:  2013-11-27       Impact factor: 3.346

4.  Zootherapeutics utilized by residents of the community Poço Dantas, Crato-CE, Brazil.

Authors:  Felipe S Ferreira; Samuel V Brito; Samuel C Ribeiro; Waltécio O Almeida; Rômulo Rn Alves
Journal:  J Ethnobiol Ethnomed       Date:  2009-08-05       Impact factor: 2.733

5.  Changes in Holstein cow milk and serum proteins during intramammary infection with three different strains of Staphylococcus aureus.

Authors:  Yunee Kim; Heba Atalla; Bonnie Mallard; Claude Robert; Niel Karrow
Journal:  BMC Vet Res       Date:  2011-09-01       Impact factor: 2.741

6.  Penetration of milk-derived antimicrobial peptides into phospholipid monolayers as model biomembranes.

Authors:  Wanda Barzyk; Ewa Rogalska; Katarzyna Więcław-Czapla
Journal:  Biochem Res Int       Date:  2013-12-17

7.  Green fluorescent protein as a scaffold for high efficiency production of functional bacteriotoxic proteins in Escherichia coli.

Authors:  Nagasundarapandian Soundrarajan; Hye-Sun Cho; Byeongyong Ahn; Minkyung Choi; Le Minh Thong; Hojun Choi; Se-Yeoun Cha; Jin-Hoi Kim; Choi-Kyu Park; Kunho Seo; Chankyu Park
Journal:  Sci Rep       Date:  2016-02-11       Impact factor: 4.379

8.  Expression and purification of coronavirus envelope proteins using a modified β-barrel construct.

Authors:  Krupakar Parthasarathy; Huang Lu; Wahyu Surya; Ardcharaporn Vararattanavech; Konstantin Pervushin; Jaume Torres
Journal:  Protein Expr Purif       Date:  2012-07-20       Impact factor: 1.650

9.  Animal-based remedies as complementary medicines in the semi-arid region of northeastern Brazil.

Authors:  Rômulo R N Alves; José A A Barbosa; Silene L D X Santos; Wedson M S Souto; Raynner R D Barboza
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-13       Impact factor: 2.629

10.  Overexpression of an antimicrobial peptide derived from C. elegans using an aggregation-prone protein coexpression system.

Authors:  Satoshi Tomisawa; Eri Hojo; Yoshitaka Umetsu; Shinya Ohki; Yusuke Kato; Mitsuhiro Miyazawa; Mineyuki Mizuguchi; Masakatsu Kamiya; Yasuhiro Kumaki; Takashi Kikukawa; Keiichi Kawano; Makoto Demura; Tomoyasu Aizawa
Journal:  AMB Express       Date:  2013-08-15       Impact factor: 3.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.